The value of histopathological prognostic factors in superficial bladder cancer: Do we need more?

Urologic Oncology

Volumn 5, Issue 5, 2000, Pages 185-190

  Witjes, J Alfred ^a   Kiemeney, Lambertus A L M ^a   Wheeless, Leon L ^a   Grossman, H Barton ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Urology ^*  (United States)

Author keywords

Bladder cancer; Cytology; Markers; Prognosis

Indexed keywords

BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033833687     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(00)00077-6     Document Type: Note

References (75)

1. Mostofi F.K., Sobin L.H., Torloni H. Histologic Typing of Urinary Bladder Tumors. International Histological Classification of Tumors, Vol. 10. 1973;The World Health Organization, Geneva.
2. Koss L.G. Atlas of Tumor Pathology. Tumors of the Urinary Bladder (Fasicle 11) 2nd ed:1975;Armed Forces Institute of Pathology, Washington, DC.
3. Prout G.R. Bladder carcinoma and a TNM system of classification. J Urol. 117:1977;583.
4. Altausen A.F., Prout G.R., Daly J.J. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol. 116:1976;575.
5. Reuter V.E., Melamed M.R. The lower urinary tract. Sternberg S.S. Diagnostic Surgical Pathology. 1989;1355 Raven Press, New York.
6. Kiemeney L.A.L.M., Witjes J.A., Heijbroek R.P., Verbeek A.L.M., Debruyne F.M.J. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol. 150:1993;60-64.
7. Witjes J.A., van der Meijden A.P.M., Collette L., Sylvester L., Debruyne F.M.J., Van Aubel A., Witjes W.P.J. Long term follow-up of an EORTC randomized prospective trial comparing intravesical BCG-RIVM and mitomycin C in superficial bladder cancer. Urology. 52:1998;403-410.
8. Vegt P.D.J., Witjes J.A., Witjes W.P.J., Doesburg W.H., Debruyne F.M.J., van der Meijden A.P.M. A randomized study of intrasvesical Mitomycin-C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. J Urol. 153:1995;929-933.
9. Witjes J.A., Kiemeney L.A.L.M., Oosterhof G.O.N., Debruyne F.M.J. Prognostic factors in superficial bladder cancer. A review. Eur Urol. 21:1992;89-97.
10. Herr H.W. Progression of stage T1 bladder tumors after intravesical Bacillus Calmette-Guerin. J Urol. 145:1991;40-44.
11. Cutler S.J., Heney N.M., Friedell G.H. Longitudinal study of patients with bladder cancer. factors associated with disease recurrence and progression Bonney W.W., Prout G.R. Jr. Bladder Cancer. AUA Monographs Vol 1. 1982;35-46 Williams & Wilkins, Baltimore, MD.
12. Heney N.M., Ahmed S., Flanagan M.J., Frable W., Corder M.P., Hafermann M.D., Hawkins IR for National Bladder Cancer Collaborative Group Superficial bladder cancer. progression and recurrence J Urol. 130:1983;1083-1086.
13. Prout G.R. Jr., Barton B.A., Griffin P., Friedell G.H. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol. 148:1992;1413-1419.
14. Mulders P.F.A., van der Meijden A.P.M., Doesburg W.H., Oosterhof G.O.N., Debruyne F.M.J. Prognostic factors in pTa-pT1 superficial bladder tumors treated with intravesical instillations. Br J Urol. 73:1994;403-408.
15. Stephenson W.T., Holmes F.F., Noble M.J., Gerald K.B. Analysis of bladder carcinoma by subsite. Cancer. 66:1990;1630-1635.
16. Loening S., Narayana A., Yoder L., Slymen D., Penick G., Culp D. Analysis of bladder tumor recurrence in 178 patients. Urology. 16:1980;137-141.
17. Schellhammer P.F., Bean M.A., Whitmore W.F. Jr. Prostatic involvement by transitional cell carcinoma. pathogenesis, patterns and prognosis J Urol. 118:1977;399-403.
18. Reading J., Hall R.R., Parmar M.K.B. The application of a prognostic factor analysis for Ta, T1 bladder cancer in routine urological practice. Br J Urol. 75:1995;604-607.
19. Lutzeyer W., Rübben H., Dahm H. Prognostic parameters in superficial bladder cancer. an analysis of 315 cases J Urol. 127:1982;250-252.
20. Dalesio O., Schulman C.C., Sylvester R.et al. Prognostic factors in superficial bladder tumors. A study of the EORTC GU Group. J Urol. 129:1983;730-733.
21. Parmar M.K.B., Freedman L.S., Hargreave T.B., Tolley D.A. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer. report from the British Medical Research Council subgroup on superficial bladder cancer J Urol. 142:1989;284-288.
22. Morgan J.D.T., Bowsher W., Griffiths D.F.R., Matthews P.N. Rationalization of follow-up in patients with non-invasive bladder tumors. A preliminary report. Br J Urol. 67:1991;158-161.
23. Fitzpatrick J.M., West A.B., Butler M.R., Lane V., O'Flynn J.D. Superficial bladder tumors (stage pTa, grades 1 and 2). the importance of recurrence pattern following initial resection J Urol. 135:1986;920.
24. Holmäng S., Hedelin H., Anderström C., Johansson L. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol. 153:1995;1823-1827.
25. Hermanek P., Sobin L.H. TNM Classification of Malignant Tumors. International Union Against Cancer. 4th edition:1987;Springer-Verlag, Heidelberg.
26. Koss L.G. Tumors of the Urinary Bladder. Atlas of Tumor Pathology, 2nd series. Fascicle 11. 1975;Armed Forces Institute of Pathology, Washington, DC.
27. Ooms E.C.M., Anderson W.A.D., Alons C.L., Boon M.E., Veldhuizen R.W. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Path. 14:1983;140-143.
28. Eble J.N., Young R.H. Benign and low grade papillary lesions of the urinary bladder. a review of the papilloma-papillary carcinoma controversy, and a report of five typical papillomas Semin Diagn Pathol. 6:1989;351-371.
29. Abel P.B., Henderson D., Bennett M.K., Hall R.R., Williams G. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol. 62:1988;339-342.
30. Lynch C.F., Platz C.E., Jones M.P., Gazzaniga J.M. Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst. 83:1991;429-433.
31. Witjes J.A., Kiemeney L.A.L.M., Schaafsma H.E., Zandberg A., Debruyne F.M.J. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Br J Urol. 73:1994;172-176.
32. Flamm J., Dona S.T. The significance of bladder quadrant biopsies in patients with primary superficial bladder cancer. Eur Urol. 16:1989;81-85.
33. Kiemeney L.A.L.M., Witjes J.A., Heijbroek R.P., Koper N.P., Verbeek A.L.M., Debruyne F.M.J. Should random urothelium biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol. 73:1994;164-171.
34. Morris S.B., Gordon E.M., Shearer R.J., Woodhouse C.R.J. Superficial bladder cancer. for how long should a tumor-free patient have check cystoscopies? Br J Urol. 75:1995;193-196.
35. Narayana A.S., Loening S.A., Slymen D.J., Culp D.A. Bladder cancer, factors affecting survival. J Urol. 130:1983;56-60.
36. Takashi M., Murase T., Mizuno S., Hamajima N., Ohno Y. Multivariate evaluation of prognostic determinants in bladder cancer patients. Urol Int. 42:1987;368-374.
37. Lipponen P.K., Collan Y., Eskelinen M.J., Pesonen E., Sotarauta M. Volume corrected mitotic index (M/V index) in human bladder cancer. relation to histological grade (WHO), clinical stage (UICC) and prognosis Scand J Urol Nephrol. 24:1990;39-45.
38. Flamm J., Havelec L. Factors affecting survival in primary superficial bladder cancer. Eur Urol. 17:1990;113-118.
39. Huland H., Kloppel G., Otto U., Droese M. The value of histologic grading and staging, random biopsies, tumor and bladder mucosa blood group antigens, in predicting progression of superficial bladder cancer. Eur Urol. 10:1984;28-31.
40. Sanchez de la Muela P., Rosell D., Aguera L.et al. Multivariate analysis of progression in superficial bladder cancer. Br J Urol. 71:1993;284-289.
41. Malmstrom P.U., Norlen B.J., Andersson B., Busch C. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder. Br J Urol. 64:1989;49-55.
42. Younes M., Sussman J., True L.D. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder. Cancer. 66:1990;543-548.
43. Hasui Y., Osada Y., Kitada S., Nishi S. Significance of invasion to the muscularis mucosa on the progression of superficial bladder cancer. Urology. 43:1994;782-786.
44. Angulo J.C., Lopez J.I., Grignon D.J., Chapado M. Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer. Urology. 45:1995;47-53.
45. Holmäng S., Hedelin H., Anderström C., Holmberg E., Johansson S.L. The importance of the depth of invasion in stage T1 bladder carcinoma. a prospective cohort study J Urol. 157:1997;800-804.
46. Smits G., Schaafsma E., Kiemeney L., Caris C., Debruyne F., Witjes J.A. Microstaging of pT1 transitional cell carcinoma of the bladder. Identification of subgroups with distinct risks for progression Urology. 52:1998;1009-1014.
47. Huland H., Otto U., Droese M. The value of urinary cytology, serum and urinary carcinoembryogenic antigen, rheumatoid factors and urinary immunoglobulin concentration as tumor markers or prognostic factors in predicting progression of superficial bladder cancer. Eur Urol. 9:1983;346-349.
48. Chopin D.K., Laurent J.C. Monoclonal antibodies in bladder cancer cytology. World J Urol. 9:1991;75-78.
49. van der Poel H.G., Boon M.E., v Stratum P., Ooms E.C.M., Wiener H., Witjes J.A., Schalken J.A., Murphy W.M. Bladder wash cytology and quantitative image analysis. Mod Pathol. 10:1997;976-982.
50. Witjes J.A., Mungan N.A., van der Poel H.G. Detection of malignant cells, can cytology be replaced. EU update series. 7:1998;73-78.
51. van der Poel H.G., van Caubergh R.D., Boon M.E., Debruyne F.M.J., Schalken J.A. Karyometry in recurrent superficial transitional cell tumors of the bladder. Urol Res. 20:1992;375-381.
52. van der Poel H.G., Oosterhof G.O.N., Debruyne F.M.J., Schalken J.A. Image analysis in superficial transitional cell carcinoma of bladder. Semin Urol. 11:1993;164-170.
53. van der Poel H.G., Witjes J.A., v Stratum P., Boon M.E., Debruyne F.M.J., Schalken J.A. Quanticyt. karyometric analysis of bladder washing for patients with superficial bladder cancer Urology. 48:1996;357-364.
54. Cajulis R.S., Haines G.K. III, Frias Hidvegi D., McVary K. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes. Anal Quant Cytol Histol. 16:1994;1-10.
55. Wheeless L.L., Reeder J.E., Han R., O'Connell M.J., Frank I.N., Cockett A.T.K., Hopman A.H.N. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Cytometry. 17:1994;319-326.
56. Griffiths T.R., Mellon J.K., Pyle G.A., Shenton B.K., Neal D.E. P53 and ploidy assessed by flow cytometry in bladder washings. Br J Urol. 776:1995;575-579.
57. Lipponen P.K., Eskelinen M.J., Nordling S. Progression and survival in transitional cell bladder cancer. a comparison of established prognostic factors, S-phase fraction and DNA ploidy Eur J Cancer. 27:1991;877.
58. Tribukait B. Flow cytometry in surgical pathology and cytology of tumors of the genito-urinary tract. Koss L.G., Coleman D.V. Advances in Clinical Cytology, Vol. 2. 1984;163-189 Masson Publishing Inc, New York.
59. Tribukait B., Gustafson H., Esposti P.L. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors. a study of 100 untreated cases Br J Urol. 54:1982;130.
60. Tachibana M., Deguchi N., Baba S., Jitsukawa S., Hata M., Tazaki H. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry. does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder J Urol. 149:1993;739.
61. Sherman A.B., Koss L.G., Adams S.E. Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal Quant Cytol Histol. 6:1984;112.
62. Saracino G.A., Ditonno P., Disabato G., Traficante A., Battaglia M., Lucivero G., Selvaggi F.P. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry. Eur Urol. 21:1992;26.
63. deVere White R.W., Deitch A.D. Evaluation of DNA flow cytometry as a screening test for bladder cancer. J Cell Biochem. suppl.)16:1992;80.
64. Liedl T. Flow cytometric DNA/cytokeratin analysis of bladder lavage. methodical aspects and clinical implications Urol Int. 54:1995;22.
65. Slaton J.W., Dinney C.P.N., Veltri L.W.et al. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. J Urol. 158:1997;806-811.
66. Lipponen P.K., Nordling S., Eskelinen M.J., Jauhiainen K., Terho R., Harju E. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional cell bladder cancer. Int J Cancer. 53:1993;42.
67. Schapers R.F., Ploem Zaaijer J.J., Pauwels R.P., Smeets A.W., vd Brandt P.A., Tanke H.J., Bosman F.T. Image cytometric DNA analysis in transitional cell carcinoma of the bladder. Cancer. 72:1993;182.
68. Norming U., Nyman C.R., Tribukait B. Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma. J Urol. 145:1991;1164-1168.
69. Norming U., Tribukait B., Nyman C.R., Nilsson B., Wang N. Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder. J Urol. 148:1992;1420-1426.
70. Colombel M.C., Pous M.F., Abbou C.C., Vanvelthoven R., Bellot J., Spyratos F., Andrieu C., de Launoit Y., Chopin D.K. Computer assisted image analysis of bladder tumor nuclei for morphonuclear and ploidy assessment. Anal Cell Pathol. 6:1994;137-147.
71. van der Poel H.G., Boon M.E., Kok L.P.et al. Morphometry, densitometry and pattern analysis of plastic embedded histologic material from urothelial cell carcinoma of the bladder. Anal Quant Cytol Histol. 13:1991;307-315.
72. Stockle M., Steinbach F., Voges G., Hohenfellner R. Image analysis DNA cytometry of bladder cancer. Recent Results Cancer Res. 126:1993;151-163.
73. Matturri L., Lavezzi A.M. Recurrent chromosome alterations in transitional cell bladder carcinomas. Eur J Histochem. 36:1992;177-186.
74. Sasaki K., Hamano K., Kinjo M., Hara S. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas. Oncology. 49:1992;219-222.
75. Wheeless L.L., Badalement R.A., deVere White R.W., Fradet Y., Tribukait B. Consensus review of clinical utility of DNA cytometry in bladder cancer. Cytometry. 14:1993;478-481.